Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Itaru Kato

Kyoto University Hospital

Japan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Articles (17)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (15)

Takashi Mikami

Assistant Professor

Kyoto University

JAPAN

View details

Takeshi Yoshida

特定講師 / Program-Specific Senior Lecturer/Program-Specific Junior Associate Professor

Kyoto University

JAPAN

View details

Yotaro Ochi

Kyoto University

JAPAN

View details

Yoshitaka Honda

特定助教 / Program-Specific Assistant Professor

Kyoto University

JAPAN

View details

James Wing

Associate Professor

Osaka University Immunology Frontier Research Center

JAPAN

View details

Hirohito Kubota

Kyoto University Hospital

JAPAN

View details

Junko Takita

教授 / Professor

Kyoto University

JAPAN

View details

Daisuke Tomizawa

Head

National Center For Child Health and Development

JAPAN

View details

Katsutsugu Umeda

講師 / Senior Lecturer/ Junior Associate Professor

Kyoto University

JAPAN

View details

Mototsugu Nagao

Lecturer

Nippon Medical School

JAPAN

View details

Yusuke Tarumoto

助教 / Assistant Professor

Kyoto University

JAPAN

View details

Hiroshi Nihira

Lecturer

Kurume University

JAPAN

View details

Satoshi Yoshihara

Professor

Hyogo medical university

JAPAN

View details

Kazushi Izawa

Kyoto University Hospital

JAPAN

View details

Takahiro Kamiya

Tokyo Medical and Dental University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Itaru Kato

Research Interests

Make your next move.

Explore related searches

Articles (17)

CAR-T cells with the CD38-CD73-Tim-3-HLA-DR+ phenotype predict the efficacy of tisagenlecleucel as a treatment for B cell precursor ALL

Pediatric Case of Non‐Islet Cell Tumor Hypoglycemia Driven by Hepatoblastoma: The Diagnostic Approach and Impact of Chemotherapy on Big IGF‐II

Combination of oral temozolomide and etoposide as palliative chemotherapy for recurrent or progressive neuroblastoma

Comparative outcomes of umbilical cord blood transplantation versus haploidentical transplantation according to post-transplant cyclophosphamide use in adolescent and young adult patients

Real-world Outcomes of Commercial Tisagenlecleucel for Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia in Japan

Multi-omics analysis identifies an M-MDSC-like immunosuppressive phenotype in lineage-switched AML with KMT2A rearrangement

Multiomics analysis reveals the genetic and epigenetic features of high-risk NK cell-type chronic active EBV infection

Clinical Impact of Immunoglobulin Heavy Chain Clonality in Pediatric B‐Cell Precursor Acute Lymphoblastic Leukemia

DLI-induced remission in recurrent EBV-associated T/NK-cell lymphoproliferative disease following HSCT: a case report

Early use of eltrombopag resulting in rapid platelet recovery in pediatric patient with newly diagnosed immune thrombocytopenia

RNA-seq–based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia

Successful cord blood transplantation using reduced intensity conditioning in a 5‐month‐old patient with IL‐10RA deficiency

MGMT protein expression is a reliable predictive biomarker for temozolomide‐containing chemotherapy in osteosarcoma

Juvenile xanthogranuloma manifesting with LCH‐associated neurodegenerative disease‐like radiological findings

Canonical BAF complex regulates the oncogenic program in human T-cell acute lymphoblastic leukemia

Successful sequential therapy with rituximab and daratumumab for refractory posttransplant immune thrombocytopenic purpura

Second relapse of FLT3‐ITD‐positive acute myeloid leukemia after discontinuation of 3‐year post‐transplant maintenance therapy with gilteritinib

Collaborators (15)

Takashi Mikami

Takeshi Yoshida

Yotaro Ochi

Yoshitaka Honda

James Wing

Hirohito Kubota

Junko Takita

Daisuke Tomizawa

Katsutsugu Umeda

Mototsugu Nagao

Yusuke Tarumoto

Hiroshi Nihira

Satoshi Yoshihara

Kazushi Izawa

Takahiro Kamiya

Make your next move.